Xtacy Therapeutics Corp (XTCY.CX)
0.05
0.00 (0.00%)
CAD |
CNSX |
May 02, 14:56
Xtacy Therapeutics PE Ratio
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| August 15, 2013 | 12.00 |
| August 14, 2013 | 16.00 |
| June 30, 2013 | |
| June 05, 2013 | 19.84 |
| May 29, 2013 | 39.69 |
| May 28, 2013 | 39.69 |
| May 08, 2013 | 52.92 |
| May 03, 2013 | 52.92 |
| March 31, 2013 |
| Date | Value |
|---|---|
| March 27, 2013 | 305.60 |
| March 25, 2013 | 764.01 |
| March 04, 2013 | 305.60 |
| March 01, 2013 | 764.01 |
| February 28, 2013 | 382.00 |
| February 08, 2013 | 38.20 |
| January 28, 2013 | 382.00 |
| January 16, 2013 | 382.00 |
| January 11, 2013 | 38.20 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
PE Ratio Related Metrics
| Price | 0.05 |
| Earnings Yield | -40.00% |
| Market Cap | 2.729M |